Advanced search
Start date
Betweenand

Study of molecular and cellular mechanisms involved in mental disorders: clinical and animal models analysis

Grant number: 19/13112-8
Support Opportunities:Research Projects - Thematic Grants
Duration: November 01, 2020 - October 31, 2026
Field of knowledge:Biological Sciences - Pharmacology - Biochemical and Molecular Pharmacology
Principal Investigator:Mirian Akemi Furuie Hayashi
Grantee:Mirian Akemi Furuie Hayashi
Host Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
Associated researchers: Alexander Birbrair ; Alexandre Keiji Tashima ; Carsten Korth ; Claudiana Lameu ; Daniele de Paula Faria ; Elisa Brietzke ; Fabio Cardoso Cruz ; Matheus de Castro Fonseca ; Patricia Pestana Garcez ; Vitor Marcelo Silveira Bueno Brandão de Oliveira
Associated scholarship(s):24/15100-5 - Analysis of oligopeptidase activity in Ndel1 conditional knockout mice, BP.IC
24/04617-7 - Analysis of oligopeptidase activity in an animal model for schizophrenia, BP.IC
23/18076-5 - Study of molecular and cellular mechanisms in disorders mental: clinical studies and animal models, BP.TT
+ associated scholarships 23/14528-9 - Analysis of angiotensin I converting enzyme activity in an animal model with altered neuronal positioning, BP.IC
23/07904-4 - Study of molecular and cellular mechanisms of mental disorders: clinical studies and animal models, BP.PD
23/07874-8 - Study of molecular and cellular mechanisms of mental disorders: clinical studies and animal models, BP.PD
23/06934-7 - Enzymatic activity of oligopeptidases Ndel1 and/or ACE in plasma or blood serum of patients with depression and bipolar disorder, BP.IC
22/00527-8 - Enzymatic activity of oligopeptidases Ndel1 and/or ACE in plasma or blood serum of patients with Depression, BP.IC - associated scholarships

Abstract

Mental disorders (MDs) are a group of potentially serious and highly prevalent diseases affecting the Central Nervous System (CNS). Studies that seek biochemical/molecular and/or cellular alterations could help in the diagnosis accuracy, as well as for the better understanding of the neurobiology involved in the MDs, thus allowing the possible identification of potential new targets for the development of innovative drugs that enable higher efficacy of the symptoms treatment, or even the MDs cure and/or possible prevention. Over the last few years, analyzes of cells maintained in culture and/or patient samples or animal models for schizophrenia (SCZ) have demonstrated that oligopeptidases, such as Ndel1, play a key role in brain formation and progression of MDs, as SCZ. The importance of oligopeptidase activity for neuritogenesis and for neuronal migration during embryogenesis and brain formation, as well as the significant differences in these oligopeptidases activity in SCZ patients compared to healthy controls, also observed in animal models for SCZ, have been demonstrated mainly by our group in last few years. At this stage of the project, we propose to carry out molecular and cellular studies, including bioinformatics analyzes, that may help to identify the pathways specifically altered in SCZ. We also propose a general evaluation of animal models (transgenics or knockouts), before and after treatment with psychostimulants and/or antipsychotics (including innovative treatments), in order to compare them with the clinical alterations already described by the group so far. We hope that this work will enable a cutting-edge new understanding of altered pathways in MD patients, with a special focus in SCZ. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications (11)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
HAYASHI, MIRIAN A. F.; SALVETAT, NICOLAS; CAYZAC, CHRISTOPHER; CHECA-ROBLES, FRANCISCO JESUS; DUBUC, BENJAMIN; MEREUZE, SANDIE; V. NANI, JOAO; MOLINA, FRANCK; BRIETZKE, ELISA; WEISSMANN, DINAH. Euthymic and depressed bipolar patients are characterized by different RNA editing patterns in blood. PSYCHIATRY RESEARCH, v. 328, p. 4-pg., . (19/08287-3, 22/03297-3, 19/09207-3, 19/13112-8, 20/01107-7, 22/00527-8, 17/02413-1, 14/50891-1)
FONSECA, MATHEUS DE CASTRO; MARAZZI-DINIZ, PAULO H. S.; LEITE, M. FATIMA; EHRLICH, BARBARA E.. Calcium signaling in chemotherapy-induced neuropathy. Cell Calcium, v. 113, p. 7-pg., . (19/13112-8)
CORREIA, BANNY SILVA BARBOSA; PONTES, JOAO GUILHERME DE MORAES; NANI, JOAO VICTOR SILVA; VILLALTA, FABIAN; MOR, NATALIA CRISTINA; BORDINI, DANIELA; BRUNONI, DECIO; BRENTANI, HELENA; MARI, JAIR JESUS; HAYASHI, MIRIAN A. F.; et al. 1H NMR Metabolomics and Lipidomics To Monitor Positive Responses in Children with Autism Spectrum Disorder Following a Guided Parental Intervention: A Pilot Study. ACS Chemical Neuroscience, v. 14, n. 6, p. 9-pg., . (19/09207-3, 18/24069-3, 14/50867-3, 19/13112-8, 20/01107-7)
SANTIAGO, THAYS CALISTA; PARRA, LARISSA; NANI, JOAO V.; FIDALGO, THIAGO M.; BRADSHAW, NICHOLAS J.; HAYASHI, MIRIAN A. F.. Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders. Journal of Neurochemistry, v. 166, n. 2, p. 18-pg., . (19/08287-3, 22/03297-3, 19/09207-3, 19/13112-8, 20/01107-7, 22/00527-8, 17/02413-1, 14/50891-1)
CAMPEIRO, JOANA D. `ARC; NANI, V, JOAP; MONTE, GABRIELA G.; ALMEIDA, PRISCILA G. C.; MORI, MARCELO A.; HAYASHI, MIRIAN A. F.. Regulation of monoamine levels by typical and atypical antipsychotics in Caenorhabditis elegans mutant for nuclear distribution element genes. NEUROCHEMISTRY INTERNATIONAL, v. 147, . (19/09207-3, 17/02413-1, 19/13112-8)
ALTAF-UL-AMIN, MD.; HIROSE, KAZUHISA; NANI, JOAO V.; PORTA, LUCAS C.; TASIC, LJUBICA; HOSSAIN, SHAIKH FARHAD; HUANG, MING; ONO, NAOAKI; HAYASHI, MIRIAN A. F.; KANAYA, SHIGEHIKO. A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorder. SCIENTIFIC REPORTS, v. 11, n. 1, . (20/01107-7, 18/03102-2, 19/09207-3, 19/13112-8)
TROMBETTA-LIMA, MARINA; ASSIS-RIBAS, THAIS; CINTRA, RICARDO C.; CAMPEIRO, JOANA D.; GUERREIRO, JULIANO R.; WINNISCHOFER, SHEILA M. B.; NASCIMENTO, ISIS C. C.; ULRICH, HENNING; HAYASHI, MIRIAN A. F.; SOGAYAR, MARI C.. Impact of Reck expression and promoter activity in neuronal in vitro differentiation. MOLECULAR BIOLOGY REPORTS, v. 48, n. 2, . (18/20014-0, 16/05311-2, 18/07366-4, 14/50891-1, 19/13112-8, 15/26328-8, 16/18277-7, 12/50880-4, 17/02413-1)
CORREIA, BANNY SILVA BARBOSA; NANI, JOAO VICTOR; WALADARES RICARDO, RANIERY; STANISIC, DANIJELA; COSTA, TASSIA BRENA BARROSO CARNEIRO; HAYASHI, MIRIAN A. F.; TASIC, LJUBICA. Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia. BIOMEDICINES, v. 9, n. 3, . (19/09207-3, 14/50867-3, 18/24069-3, 19/13112-8, 17/02413-1)

Please report errors in scientific publications list using this form.
X

Report errors in this page


Error details: